Analyzing factors influencing hospitalization costs for five common cancers in China using neural network models.

Journal: Journal of medical economics
PMID:

Abstract

BACKGROUND: Malignant tumors are a major global health crisis, causing 25% of deaths in China, with lung, liver, thyroid, breast, and colon cancers being the most common. Understanding the factors influencing hospitalization costs for these cancers is crucial for public health and economics. This study aimed to identify key cost factors and develop a neural network model for predicting hospitalization costs, thereby providing tools to ease the financial burden on patients and healthcare systems.

Authors

  • Hong Jiang
    Department of Neurosurgery, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Sinuo Ren
    School of Automation Science and Electrical Engineering, Beihang University, Beijing, China.
  • Shengbo Zhang
    Department of General Surgery, Zhuhai People's Hospital (The Affiliated Hospital of Beijing Institute of Technology, Zhuhai Clinical Medical College of Jinan University), Zhuhai, China.
  • Xudan Luo
    Department of Industrial Engineering and Operations Research, University of California, Berkeley, CA, USA.
  • Rui He
    Faculty of Information Technology, Beijing University of Technology, Beijing 100124, China. herui@emails.bjut.edu.cn.
  • Shuai Fei Wang
    Statistical office, Zhuhai People's Hospital (The Affiliated Hospital of Beijing Institute of Technology, Zhuhai Clinical Medical College of Jinan University), Zhuhai, China.
  • Jian Dong Yan
    Statistical office, Zhuhai People's Hospital (The Affiliated Hospital of Beijing Institute of Technology, Zhuhai Clinical Medical College of Jinan University), Zhuhai, China.
  • Shan Zhou
    Florida Research and Innovation Center, Cleveland Clinic, Port St. Lucie, FL, USA.
  • Chengliang Yin
    Faculty of Medicine, Macau University of Science and Technology, Macau, People's Republic of China.
  • Ying Xiao
    Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.
  • Zhihuan Li
    Center for Translational Innovations and Department of Respiratory and Critical Care Medicine, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, China; Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Guangzhou, China.